Vineet Laboratories profitability ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Returns
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
5.3%5.3%−81.8%3.0%3.7%
1.5%1.5%−19.1%0.9%1.1%
15.6%15.6%−61.6%11.4%12.8%
10.8%7.1%−33.6%5.9%5.1%
Margins
16.7%14.3%−21.7%4.8%3.6%
10.2%10.2%−25.1%3.1%2.5%
—−159.3%31.0%1.0%—
4.8%2.2%−27.7%0.2%1.0%
6.4%2.7%−26.9%0.7%0.6%
−22.6%−22.6%13.9%−7.7%−8.1%
Additional
−17.6%13.4%2.8%−182.6%38.3%
—0.0%0.0%0.0%73.6%
5.3%5.3%−81.8%3.0%1.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

VINEETLAB₹37.76

Vineet Laboratories Limited

· Pharma & Health
₹ CrorePeersBIOFILCHEMMANGALAMLASAKREBSBIOALPABALPHARMAORTINGLOBENATCAPSUQMcap ₹72.5 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity3.723.00-81.795.325.32
Return on Assets1.080.88-19.101.461.46
Return on Capital Employed12.7911.39-61.5615.6215.62
Return on Invested Capital5.095.94-33.577.0810.80
Margins
EBITDA Margin3.614.78-21.7114.2716.70
Operating Margin2.493.11-25.0510.2110.21
Incremental Operating Margin—0.9831.04-159.35—
Pretax Margin0.960.24-27.702.164.76
Net Income Margin0.590.68-26.922.706.39
FCF Margin-8.13-7.7413.93-22.63-22.63
Additional
Effective Tax Rate38.30-182.642.8113.39-17.55
Dvd Payout Ratio73.600.00-0.000.00—
Sustainable Growth Rate0.983.00-81.795.325.32
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.